Hypergammaglobulinemia natural history: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 8: | Line 8: | ||
==Complications== | ==Complications== | ||
Common complications of x-linked hyper-Ig M include:<ref name="pmid19597006">{{cite journal| author=Fried AJ, Bonilla FA| title=Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections. | journal=Clin Microbiol Rev | year= 2009 | volume= 22 | issue= 3 | pages= 396-414 | pmid=19597006 | doi=10.1128/CMR.00001-09 | pmc=PMC2708392 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19597006 }} </ref> | *Common complications of x-linked hyper-Ig M include:<ref name="pmid19597006">{{cite journal| author=Fried AJ, Bonilla FA| title=Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections. | journal=Clin Microbiol Rev | year= 2009 | volume= 22 | issue= 3 | pages= 396-414 | pmid=19597006 | doi=10.1128/CMR.00001-09 | pmc=PMC2708392 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19597006 }} </ref> | ||
*Infection | **Infection | ||
**Viral | ***Viral | ||
***Disseminated cytomegalovirus and herpes simplex virus infections | ****Disseminated cytomegalovirus and herpes simplex virus infections | ||
**Bacterial | ***Bacterial | ||
***Cholangitis from Cryptosporidium parvum | ****Cholangitis from Cryptosporidium parvum | ||
**Fungal | ***Fungal | ||
***Disseminated | ****Disseminated | ||
***Opportunistic Pneumocystis jirovecii pneumonia infections | ****Opportunistic Pneumocystis jirovecii pneumonia infections | ||
*Gastrointestinal tumors | **Gastrointestinal tumors | ||
*The activation-induced cysteine deaminase deficient patients are at an increased risk of developing inflammatory as well as autoimmune diseases like autoimmune hemolytic anemia and autoimmune thrombocytopenia.<ref name="pmid14962793">{{cite journal| author=Quartier P, Bustamante J, Sanal O, Plebani A, Debré M, Deville A et al.| title=Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency. | journal=Clin Immunol | year= 2004 | volume= 110 | issue= 1 | pages= 22-9 | pmid=14962793 | doi=10.1016/j.clim.2003.10.007 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14962793 }} </ref> | |||
==Prognosis== | ==Prognosis== |
Revision as of 14:13, 2 March 2016
Hypergammaglobulinemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hypergammaglobulinemia natural history On the Web |
American Roentgen Ray Society Images of Hypergammaglobulinemia natural history |
Risk calculators and risk factors for Hypergammaglobulinemia natural history |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Soujanya Thummathati, MBBS [2]
Overview
Natural History
Complications
- Common complications of x-linked hyper-Ig M include:[1]
- Infection
- Viral
- Disseminated cytomegalovirus and herpes simplex virus infections
- Bacterial
- Cholangitis from Cryptosporidium parvum
- Fungal
- Disseminated
- Opportunistic Pneumocystis jirovecii pneumonia infections
- Viral
- Gastrointestinal tumors
- Infection
- The activation-induced cysteine deaminase deficient patients are at an increased risk of developing inflammatory as well as autoimmune diseases like autoimmune hemolytic anemia and autoimmune thrombocytopenia.[2]
Prognosis
References
- ↑ Fried AJ, Bonilla FA (2009). "Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections". Clin Microbiol Rev. 22 (3): 396–414. doi:10.1128/CMR.00001-09. PMC 2708392. PMID 19597006.
- ↑ Quartier P, Bustamante J, Sanal O, Plebani A, Debré M, Deville A; et al. (2004). "Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency". Clin Immunol. 110 (1): 22–9. doi:10.1016/j.clim.2003.10.007. PMID 14962793.